UVXY News 57.41 04/25/2014 06:18:40 Ultra VIX Short-Term Fut

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ultra VIX Short-Term Fut ETF Proshares (UVXY) 57.41 $UVXY

The Market's Winning Streak Ends
at The Street - Wed Apr 23, 4:17PM CDT
The winning streak for the Nasdaq, Russell 2000, and the S&P 500 ended on Wednesday at six days in a row. Volume was pathetic once again, which is a very bad sign.

S&P, Nasdaq, Russell on 6-Day Win Streak
at The Street - Tue Apr 22, 4:22PM CDT
Volume, however, continues to be a major concern on the upside.

Carnage in the Nasdaq and Russell 2000 Indexes
at The Street - Mon Apr 07, 4:12PM CDT
The selling continued as both the Nasdaq and Russell 2000 have entered into Trend Bearish territory.

DJIA and S&P Finally Succumb to the Nasdaq and Russell 2000
at The Street - Fri Apr 04, 4:12PM CDT
The DJIA and S&P 500 finally see some serious selling pressure.

DJIA, S&P 500 Continue to Outperform Others
at The Street - Thu Apr 03, 4:48PM CDT
The DJIA and the S&P 500 continue to outperform the Nasdaq and Russell 2000 on a daily basis. This is not good news for the intermediate term.

Another All-Time Bubble High for the S&P 500
at The Street - Wed Apr 02, 4:38PM CDT
The S&P 500 set another all-time bubble high as the short hedge funds scrambled to buy the high after selling the low last week.

Volatility ETFs Crash as Market Fears Drop - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 1:00PM CST
Thanks to declining worries about the market, volatility ETNs have lost all of their 2014 momentum.

Volatility ETFs Skyrocket on Broad Market Weakness - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Mon Feb 03, 9:00AM CST
Inside the incredible run in the volatility ETF market over the past ten days.

What This Indicator Is Saying About the S&P 500
Lee Samaha, The Motley Fool - Motley Fool - Mon Dec 30, 6:00PM CST
There is no such thing as a magic indicator that will tell you when to buy and sell the S&P 500 , and we Fools do not recommend timing the market. However, Foolish investors can use the following indicator to decide whether to be fearful of a...

The Two Month VIX Cycle
Chad Karnes - ETFG - Fri Nov 15, 7:37PM CST
Buying the VIX is a great way to hedge your portfolio, if you can get the timing right. Luckily, the VIX has provided us some excellent technical clues that we can combine with the uncertainty from Washington to come up with some great VIX trades.

Are VIX Traders Riding the Wrong Roller Coaster?
Ron DeLegge - ETFG - Thu Oct 24, 9:58PM CDT
We highlight the performance discrepancies between the VIX and VIX ETPs and why traders need to understand the difference.

Is a Fearless Stock Market Cause for Concern?
Chad Karnes - ETFG - Wed Aug 14, 7:38PM CDT
The VIX can often signal a peak in stock market prices. By flipping it, it will typically move up and down along with the market and can sometimes be easier to help identify major market turning points.

Volatility Is On My Mind - Analyst Blog
Nick Kalivas - Zacks Investment Research - Fri Aug 02, 3:45PM CDT
S&P 500 30 day historical volatility is getting low. It???s worth watching.

A Common Sense View for Investing in Stocks
Chad Karnes - ETFG - Tue Jun 18, 3:31PM CDT
A little common sense can go a long way. After a 4 year non-stop market rally, long-term investors really should take a step back and wonder if they are just chasing returns or actually making good purchase decisions.

Unemployment: Is Resilience an Illusion? - Analyst Blog
Abhijit Ghosh - Zacks Investment Research - Thu May 16, 12:58PM CDT
After sinking to a five-year low last week, jobless claims have now jumped to a seasonally adjusted level of 360,000.

Why I Hate Volatility ETFs (And Why You Should Too) - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu May 02, 3:04PM CDT
Why investors would be better served by avoiding volatility ETFs like VXX over long time periods.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 138

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 84

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 113

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Visit W&H at the Greater New York Dental Meeting

Updated Category News Views 89

Why This Event Matters for Dental Professionals Stroll through any convention center halls and you can see the future unfolding right in front of you. The upcoming Greater New York Dental Meeting is no different, especially with W&H Group setting up shop. For any dental professionals out there, this is your chance to get your hands on some real-deal tech that might just...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 100

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 162

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Greenberg Traurig Cheers Clients' 69th GRAMMY® Nods

Updated Category News Views 49

A Momentous Occasion for Greenberg Traurig's Entertainment Clients Oh, the glamour and glitz of the music world! There's nothing quite like the GRAMMY® Awards to stir up a blend of excitement, ego, and anxiety in the industry. This time around, the lawyers over at Greenberg Traurig are beaming with pride as their clients scoop up nominations for the 69th Annual GRAMMY®...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 195

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 103

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
SKE Capitalizes on Halloween Events in London

Updated Category News Views 104

SKE's Bold Step into London's Halloween Vibe Hah! Who would've thought that vaping and Halloween could be a match made in heaven? This year, SKE threw its hat into the ring and wrestled for attention in London’s bustling Halloween music scene. Imagine an entire warehouse pulsing not just with beat-heavy electronic music, but the energy of vaping enthusiasts courtesy of...

Continue Reading

Top 5 Most Recently Viewed Articles

Why Investors Are Making Bold Moves with Dell Technologies

Updated Category News Views 178

Investors Show Confidence in Dell Technologies In recent trading sessions, significant investors have adopted a bullish approach to Dell Technologies (NYSE: DELL). Such movements usually signal investor confidence and the possibility of future price movements. Interestingly, options trading data we've analyzed indicates that this activity stemmed from large transactions,...

Continue Reading
Community Heritage Financial Strengthens Capital Position with Debt Offering

Updated Category News Views 78

Community Heritage Financial Completes Subordinated Debt Offering Community Heritage Financial, Inc. (OTC PK: CMHF), parent company of Middletown Valley Bank, has successfully executed a private placement of subordinated debt, amounting to a substantial $12.1 million. This offering of 6.75% Fixed-to-Floating Rate Subordinated Notes, due 2034, reflects the Company’s...

Continue Reading
Evolent Health Poised for Growth Amid Humana Challenges

Updated Category News Views 185

Understanding Evolent Health's Market Position Recently, analysts at Barclays have reaffirmed their positive outlook on Evolent Health (NYSE: EVH), maintaining an Overweight rating and a price target of $39.00. This confidence comes in light of discussions surrounding the impacts of Humana's recent struggles with Medicare Star ratings. The management team at Evolent,...

Continue Reading
Caracole Teams with Centric PLM for Seamless Growth

Updated Category News Views 31

Revolutionizing the Luxury Furniture Game In the world of luxury furnishings, where every curve and finish sends a message, Caracole is making a bold move to streamline its operations. They're throwing the confetti for Centric PLM, a platform that's set to oust the scattered chaos of spreadsheets and emails. And let me tell you, for any investor eyeing the luxury home...

Continue Reading
RaySearch Laboratories: Exciting Year-End Presentation Ahead

Updated Category News Views 105

Join Us for RaySearch Laboratories' Year-End Report Presentation Analysts, investors, and media representatives are cordially invited to a detailed presentation focused on RaySearch Laboratories' Year-end report for the year 2024. Details of the Presentation Set for February 21, 2025, at 10:00 AM CET, the report will be made accessible to attendees starting at 07:45 AM on...

Continue Reading